ALPINE IMMUNE SCIENCES, INC. Cash and Restricted Cash
ALPINE IMMUNE SCIENCES, INC. had Cash and Restricted Cash of $33.28 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-05-09
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.28M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $44.19M.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.23M.
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $34.33M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2024-03-31 | $33.28M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $44.19M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $19.23M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $34.33M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $14.72M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $13.63M 10-Q · filed 2024-05-09 |
| 2022-09-30 | $126.88M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $24.61M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $35.14M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $68.16M 10-K · filed 2024-03-20 |
| 2021-09-30 | $76.35M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $19.07M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $12.88M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $35.21M 10-K · filed 2024-03-20 |
| 2020-09-30 | $141.33M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $88.47M 10-Q · filed 2021-08-10 |
| 2020-03-31 | $24.83M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $16.51M 10-K · filed 2023-03-23 |
| 2019-09-30 | $17.78M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $15.85M 10-Q · filed 2020-08-11 |
| 2019-03-31 | $41.82M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $10.84M 10-K · filed 2022-03-17 |
| 2018-09-30 | $11.61M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $3.70M 10-Q · filed 2019-08-13 |
| 2018-03-31 | $7.58M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $8.13M 10-K · filed 2021-03-18 |
| 2017-09-30 | $12.11M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $31.24M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $13.57M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $11.82M 10-K · filed 2020-03-30 |
| 2016-09-30 | $13.96M 10-Q · filed 2017-11-14 |
| 2015-12-31 | $5.42M 10-K · filed 2019-03-18 |